VH2-16443-23721
3 vaccinations
6 coded responses
34 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 787 / TX
- Registered
- 2021-11-06
- Relationship
- Child or adolescent in my care
- Guardian
- YSE-32908-41485
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-11-06
Registered in v-safe
-
2021-11-06
Dose 1 — Pfizer-BioNTech
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-12
- 2021-11-18
- 2021-11-20
-
2021-11-27
Dose 2 — Pfizer-BioNTech
- 2021-11-27
-
2021-11-28
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Cough, Pre-existing disease, Rhinorrhoea — Feeling: FairFree text: Allergies- runny nose and coughMedDRA releases: 2024-11 · check-in free text available
- 2021-11-29
- 2021-11-30
- 2021-12-01
- 2021-12-04
- 2021-12-11
- 2021-12-18
-
2022-01-01
Survey response — day 35, dose 2, dependentMedDRA: Nasopharyngitis — Feeling: GoodFree text: Minor coldMedDRA releases: 2024-11 · check-in free text available
-
2022-01-08
Survey response — day 42, dose 2, dependentMedDRA: Cough, Pre-existing disease, Respiratory tract congestion — Feeling: GoodFree text: Allergies - Congestion coughMedDRA releases: 2024-11 · check-in free text available
- 2022-02-26
-
2022-05-30
Survey response — 6 months, dose 2, dependentMedDRA: Nasopharyngitis, Viral infection — Feeling: GoodFree text: Cold/virusMedDRA releases: 2024-11 · check-in free text available
-
2022-06-01
Dose 3 — Pfizer-BioNTechCo-administered: HPV
-
2022-06-02
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2022-06-03
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-06-04
- 2022-06-05
- 2022-06-06
- 2022-06-07
- 2022-06-08
- 2022-06-15
- 2022-06-22
- 2022-06-30
- 2022-07-06
- 2022-07-13
-
2022-08-31
Survey response — 3 months, dose 3, dependentMedDRA: Oropharyngeal pain, Respiratory tract congestion, Viral infection — Feeling: GoodFree text: Congestion and sore throat from a virusMedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Survey response — 6 months, dose 3, dependentMedDRA: Nasopharyngitis, Viral infection — Feeling: Good · Be unable to work or attend schoolFree text: Some sort of cold/ virus- all better nowMedDRA releases: 2024-11 · check-in free text available
- 2023-06-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-06 | Pfizer-BioNTech | No |
| 2 | 2021-11-27 | Pfizer-BioNTech | No |
| 3 | 2022-06-01 | Pfizer-BioNTech | HPV |
Free text
Release 10 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Allergies- runny nose and cough
Release 10 — day 35, dose 2, dependent
Symptoms: Minor cold
Release 10 — day 42, dose 2, dependent
Symptoms: Allergies - Congestion cough
Release 11 — 6 months, dose 2, dependent
Symptoms: Cold/virus
Release 12 — 3 months, dose 3, dependent
Symptoms: Congestion and sore throat from a virus
Release 12 — 6 months, dose 3, dependent
Symptoms: Some sort of cold/ virus- all better now
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release